the future of treatment in lung cancer," lead author Dr. Edward Kim, an assistant professor in the department of thoracic/head and neck medical oncology at M.D. Anderson Cancer Center in Houston, said in a news release. "Blocking more key cancer pathways such as the epidermal growth factor receptor and vascular endothelial growth factor may lead to improved cancer control."
In 2008, about 215,000 new cases of lung cancer will be diagnosed in the United States and 161,840 people will die from the disease, according to the U.S. National Cancer Institute.
More information
The American Cancer Society has more about non-small cell lung cancer.
-- Robert Preidt
SOURCE: American Society for Therapeutic Radiology and Oncology, news releases, Nov. 13, 2008
'/>"/>Copyright©2008 ScoutNews,LLC. All rights reserved | |
Page: 1 2 Related medicine news :1.
Cancer treatment may result in bone loss2.
American Academy of Dermatology: Stop Skin Cancer On The Spot3.
Gender is key factor in determining overall survival of lung cancer patients4.
Proton therapy may reduce serious side effect of lung cancer treatment5.
Tissue analyses indicate survival benefits for some lung cancer patients6.
Advanced lung cancer patients see improved, progression-free survival7.
Chemotherapy plus targeted therapies shows improved survival in advance-stage lung cancer patients8.
Research demonstrates differing genetic makeup of lung cancer in African-American patients9.
Novel 4-drug combination proves safe for lung cancer treatment10.
US Oncology Applauds Senator Baucuss Healthcare Reform Call to Action for 2009, Supports Collaborative Measures to Enhance Cancer Patients Access to Care While Improving Quality and Access11.
AACR to host 7th Annual International Conference on Frontiers in Cancer Prevention Research